SIRT1 and hepatocellular carcinoma: SIRT1 is upregulated in the majority of hepatocellular carcinomas (HCCs) and enhances the invasive and metastatic potential of HCC by activating EMT markers, such as SNAIL, TWIST, and VIMENTIN, and inhibiting E-cadherin.